The s-APEX1 level was markedly increased in patients with HBV DNA (+), primary ccRCC, HCC, or CC, and the s-APEX1 levels exhibited positive correlations with AST, ALT, GGT, CRP, and HBV DNA (+). Here, APEX1 is linked to cholangiocarcinoma.